当前位置:首页 - 行情中心 - 硕世生物(688399) - 财务分析 - 现金流量表

硕世生物

(688399)

  

流通市值:53.59亿  总市值:53.59亿
流通股本:8387.17万   总股本:8387.17万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金178,751,188.3494,839,811.21473,244,427.8379,338,265.61
  收到的税费返还249,891.45160,366.6833,967.56479,442.15
  收到其他与经营活动有关的现金15,841,458.4212,698,772.37105,724,030.1964,828,292.04
  经营活动现金流入小计194,842,538.21107,698,950.18579,802,425.55444,645,999.8
  购买商品、接受劳务支付的现金49,621,065.0629,238,486.9675,777,350.6269,749,296.19
  支付给职工以及为职工支付的现金82,334,999.0241,855,416.88210,815,749.17164,641,483.18
  支付的各项税费9,189,545.394,523,553.2717,706,583.2913,732,639.88
  支付其他与经营活动有关的现金54,272,568.5427,814,237.84129,577,430.9499,902,079.98
  经营活动现金流出小计195,418,178.01103,431,694.95433,877,114.02348,025,499.23
  经营活动产生的现金流量净额-575,639.84,267,255.23145,925,311.5396,620,500.57
二、投资活动产生的现金流量:
  收回投资收到的现金2,390,726,848.831,284,127,379.022,357,197,275.061,886,770,301.22
  取得投资收益收到的现金323,629.021,284,793.99--
  处置固定资产、无形资产和其他长期资产收回的现金净额860,115.3414,759.194,234,621.823,260,092.3
  收到的其他与投资活动有关的现金--130,008,906.0830,000,000
  投资活动现金流入小计2,391,910,593.151,285,826,932.22,491,440,802.961,920,030,393.52
  购建固定资产、无形资产和其他长期资产支付的现金35,341,562.725,763,683.2862,861,301.7960,038,411.18
  投资支付的现金2,834,371,918.591,900,416,693.923,301,592,708.852,491,698,243.65
  投资活动现金流出小计2,869,713,481.311,906,180,377.23,364,454,010.642,551,736,654.83
  投资活动产生的现金流量净额-477,802,888.16-620,353,445-873,013,207.68-631,706,261.31
三、筹资活动产生的现金流量:
  取得借款收到的现金404,900,000267,900,000442,500,000302,900,000
  筹资活动现金流入小计404,900,000267,900,000442,500,000302,900,000
  偿还债务支付的现金235,000,000130,000,000371,803,000147,803,000
  分配股利、利润或偿付利息支付的现金3,554,078.711,392,361.227,077,171.155,516,390.47
  支付其他与筹资活动有关的现金2,596,916.021,254,419.92158,375,330.81153,149,176.94
  筹资活动现金流出小计241,150,994.73132,646,781.14537,255,501.96306,468,567.41
  筹资活动产生的现金流量净额163,749,005.27135,253,218.86-94,755,501.96-3,568,567.41
四、汇率变动对现金及现金等价物的影响84,913.99116,855.06849,714.75-1,439,272.66
五、现金及现金等价物净增加额-314,544,608.7-480,716,115.85-820,993,683.36-540,093,600.81
  加:期初现金及现金等价物余额810,008,120.6810,008,120.61,631,001,803.961,631,001,803.96
  期末现金及现金等价物余额495,463,511.9329,292,004.75810,008,120.61,090,908,203.15
补充资料:
  净利润3,992,614.61--2,001,695.81-
  资产减值准备8,875,990.18-25,015,532.3-
  固定资产和投资性房地产折旧24,061,207.33-48,520,362.26-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧24,061,207.33-48,520,362.26-
  无形资产摊销1,159,973.32-2,527,744.38-
  长期待摊费用摊销8,454,134.1-20,569,072.84-
  处置固定资产、无形资产和其他长期资产的损失-329,458.59--2,223,291.77-
  固定资产报废损失13,877.86-153,324.03-
  公允价值变动损失-24,119,828.2--2,182,658.64-
  财务费用5,140,158.69-6,647,854.54-
  投资损失-3,678,436.1-1,350,660.89-
  递延所得税3,020,246.11-6,251,840.24-
  其中:递延所得税资产减少3,020,246.11-6,254,683.78-
    递延所得税负债增加---2,843.54-
  存货的减少6,646,044.57-11,131,231.79-
  经营性应收项目的减少35,539,325.34-16,853,310.68-
  经营性应付项目的增加-67,466,454.1-41,739,592.72-
  其他55,902.15-31,296.24-
  现金的期末余额495,463,511.9-810,008,120.6-
  减:现金的期初余额810,008,120.6-1,631,001,803.96-
  现金及现金等价物的净增加额-314,544,608.7--820,993,683.36-
公告日期2025-08-092025-04-302025-04-192024-10-26
审计意见(境内)标准无保留意见
TOP↑